Cannabinoids attenuate cancer pain and proliferation in a mouse model

Negin Saghafi, David K. Lam, Brian Schmidt

Research output: Contribution to journalArticle

Abstract

We investigated the effects of cannabinoid receptor agonists on (1) oral cancer cell viability in vitro and (2) oral cancer pain and tumor growth in a mouse cancer model. We utilized immunohistochemistry and Western blot to show that human oral cancer cells express CBr1 and CBr2. When treated with WIN55,212-2 (non-selective), ACEA (CBr1-selective) or AM1241 (CBr2-selective) agonists in vitro, oral cancer cell proliferation was significantly attenuated in a dose-dependent manner. In vivo, systemic administration (0.013. M) of WIN55,212-2, ACEA, or AM1241 significantly attenuated cancer-induced mechanical allodynia. Tumor growth was also significantly attenuated with systemic AM1241 administration. Our findings suggest a direct role for cannabinoid mechanisms in oral cancer pain and proliferation. The systemic administration of cannabinoid receptor agonists may have important therapeutic implications wherein cannabinoid receptor agonists may reduce morbidity and mortality of oral cancer.

Original languageEnglish (US)
Pages (from-to)247-251
Number of pages5
JournalNeuroscience Letters
Volume488
Issue number3
DOIs
StatePublished - Jan 25 2011

Fingerprint

Cannabinoids
Mouth Neoplasms
Cannabinoid Receptor Agonists
Neoplasms
Hyperalgesia
Growth
Cancer Pain
Cell Survival
Western Blotting
Immunohistochemistry
Cell Proliferation
Morbidity
Mortality
AM 1241

Keywords

  • Cancer mouse model
  • Cancer pain
  • Cannabinoids
  • CB1 receptor
  • CB2 receptor
  • Cell viability

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Cannabinoids attenuate cancer pain and proliferation in a mouse model. / Saghafi, Negin; Lam, David K.; Schmidt, Brian.

In: Neuroscience Letters, Vol. 488, No. 3, 25.01.2011, p. 247-251.

Research output: Contribution to journalArticle

Saghafi, Negin ; Lam, David K. ; Schmidt, Brian. / Cannabinoids attenuate cancer pain and proliferation in a mouse model. In: Neuroscience Letters. 2011 ; Vol. 488, No. 3. pp. 247-251.
@article{bdab5659c8574babbf947880e47b5ba0,
title = "Cannabinoids attenuate cancer pain and proliferation in a mouse model",
abstract = "We investigated the effects of cannabinoid receptor agonists on (1) oral cancer cell viability in vitro and (2) oral cancer pain and tumor growth in a mouse cancer model. We utilized immunohistochemistry and Western blot to show that human oral cancer cells express CBr1 and CBr2. When treated with WIN55,212-2 (non-selective), ACEA (CBr1-selective) or AM1241 (CBr2-selective) agonists in vitro, oral cancer cell proliferation was significantly attenuated in a dose-dependent manner. In vivo, systemic administration (0.013. M) of WIN55,212-2, ACEA, or AM1241 significantly attenuated cancer-induced mechanical allodynia. Tumor growth was also significantly attenuated with systemic AM1241 administration. Our findings suggest a direct role for cannabinoid mechanisms in oral cancer pain and proliferation. The systemic administration of cannabinoid receptor agonists may have important therapeutic implications wherein cannabinoid receptor agonists may reduce morbidity and mortality of oral cancer.",
keywords = "Cancer mouse model, Cancer pain, Cannabinoids, CB1 receptor, CB2 receptor, Cell viability",
author = "Negin Saghafi and Lam, {David K.} and Brian Schmidt",
year = "2011",
month = "1",
day = "25",
doi = "10.1016/j.neulet.2010.11.039",
language = "English (US)",
volume = "488",
pages = "247--251",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Cannabinoids attenuate cancer pain and proliferation in a mouse model

AU - Saghafi, Negin

AU - Lam, David K.

AU - Schmidt, Brian

PY - 2011/1/25

Y1 - 2011/1/25

N2 - We investigated the effects of cannabinoid receptor agonists on (1) oral cancer cell viability in vitro and (2) oral cancer pain and tumor growth in a mouse cancer model. We utilized immunohistochemistry and Western blot to show that human oral cancer cells express CBr1 and CBr2. When treated with WIN55,212-2 (non-selective), ACEA (CBr1-selective) or AM1241 (CBr2-selective) agonists in vitro, oral cancer cell proliferation was significantly attenuated in a dose-dependent manner. In vivo, systemic administration (0.013. M) of WIN55,212-2, ACEA, or AM1241 significantly attenuated cancer-induced mechanical allodynia. Tumor growth was also significantly attenuated with systemic AM1241 administration. Our findings suggest a direct role for cannabinoid mechanisms in oral cancer pain and proliferation. The systemic administration of cannabinoid receptor agonists may have important therapeutic implications wherein cannabinoid receptor agonists may reduce morbidity and mortality of oral cancer.

AB - We investigated the effects of cannabinoid receptor agonists on (1) oral cancer cell viability in vitro and (2) oral cancer pain and tumor growth in a mouse cancer model. We utilized immunohistochemistry and Western blot to show that human oral cancer cells express CBr1 and CBr2. When treated with WIN55,212-2 (non-selective), ACEA (CBr1-selective) or AM1241 (CBr2-selective) agonists in vitro, oral cancer cell proliferation was significantly attenuated in a dose-dependent manner. In vivo, systemic administration (0.013. M) of WIN55,212-2, ACEA, or AM1241 significantly attenuated cancer-induced mechanical allodynia. Tumor growth was also significantly attenuated with systemic AM1241 administration. Our findings suggest a direct role for cannabinoid mechanisms in oral cancer pain and proliferation. The systemic administration of cannabinoid receptor agonists may have important therapeutic implications wherein cannabinoid receptor agonists may reduce morbidity and mortality of oral cancer.

KW - Cancer mouse model

KW - Cancer pain

KW - Cannabinoids

KW - CB1 receptor

KW - CB2 receptor

KW - Cell viability

UR - http://www.scopus.com/inward/record.url?scp=78650805812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650805812&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2010.11.039

DO - 10.1016/j.neulet.2010.11.039

M3 - Article

VL - 488

SP - 247

EP - 251

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -